Its behavior from early stages to late stages of malignancy was broadly investigated by Kraus et al. As a biomarker for the early detection of cancer, CD24 is over expressed at the early stages of the disease, for example, at the polyp stage in colorectal cancer. Here, CD24 is linked to colorectal cancer.